GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 3,382 | 1,513 | 1,932 | 3,763 | 3,604 |
| Operating Income | -3,382 | -1,513 | -1,932 | -3,763 | -3,604 |
| Other Income | 268 | 80 | 1,156 | -12 | 193 |
| Pre-tax Income | -3,114 | -1,433 | -776 | -3,775 | -3,411 |
| Net Income Continuous | -3,114 | -1,433 | -776 | -3,775 | -3,411 |
| Net Income | $-3,114 | $-1,433 | $-776 | $-3,775 | $-3,411 |
| EPS Basic Total Ops | -0.83 | -0.55 | -0.33 | -1.60 | -1.53 |
| EPS Basic Continuous Ops | -0.79 | -0.52 | -0.33 | -1.60 | -1.53 |
| EPS Diluted Total Ops | -0.83 | -0.55 | -0.33 | -1.60 | -1.53 |
| EPS Diluted Continuous Ops | -0.79 | -0.52 | -0.33 | -1.60 | -1.53 |
| EPS Diluted Before Non-Recurring Items | -0.83 | -0.55 | -0.76 | -1.66 | -1.53 |
| EBITDA(a) | $-3,382 | $-1,513 | $-1,932 | $-3,763 | $-3,604 |